These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27981812)

  • 1. Take Care of the Fast-in-Human Study.
    van Hoogdalem EJ
    Clin Transl Sci; 2017 May; 10(3):122-123. PubMed ID: 27981812
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety, Tolerability, and Pharmacokinetics of FAAH Inhibitor BIA 10-2474: A Double-Blind, Randomized, Placebo-Controlled Study in Healthy Volunteers.
    Rocha JF; Santos A; Gama H; Moser P; Falcão A; Pressman P; Wallace Hayes A; Soares-da-Silva P
    Clin Pharmacol Ther; 2022 Feb; 111(2):391-403. PubMed ID: 33998672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons from the fatal French study BIA-10-2474.
    Moore N
    BMJ; 2016 May; 353():i2727. PubMed ID: 27193592
    [No Abstract]   [Full Text] [Related]  

  • 4. FAAH inhibitors in the limelight, but regrettably.
    Mallet C; Dubray C; Dualé C
    Int J Clin Pharmacol Ther; 2016 Jul; 54(7):498-501. PubMed ID: 27191771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary: Fatal French Clinical Trial: What Can We Learn from What Went Wrong?
    Skaper SD
    CNS Neurol Disord Drug Targets; 2016; 15(7):752-3. PubMed ID: 27549166
    [No Abstract]   [Full Text] [Related]  

  • 6. Commentary on BIA 10-2474.
    Hayes AW
    Regul Toxicol Pharmacol; 2020 Mar; 111():104541. PubMed ID: 31759139
    [No Abstract]   [Full Text] [Related]  

  • 7. Discovery of a Potent, Long-Acting, and CNS-Active Inhibitor (BIA 10-2474) of Fatty Acid Amide Hydrolase.
    Kiss LE; Beliaev A; Ferreira HS; Rosa CP; Bonifácio MJ; Loureiro AI; Pires NM; Palma PN; Soares-da-Silva P
    ChemMedChem; 2018 Oct; 13(20):2177-2188. PubMed ID: 30113139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tirbanibulin (Klisyri) for the Treatment of Actinic Keratosis.
    Geer K
    Am Fam Physician; 2021 Nov; 104(5):519-520. PubMed ID: 34783508
    [No Abstract]   [Full Text] [Related]  

  • 9. Lead Essay: Money, Equity and Access to Medicines.
    Ghinea N; Lipworth W; Kerridge I
    J Bioeth Inq; 2020 Mar; 17(1):25-27. PubMed ID: 32124176
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase.
    Kerbrat A; Ferré JC; Fillatre P; Ronzière T; Vannier S; Carsin-Nicol B; Lavoué S; Vérin M; Gauvrit JY; Le Tulzo Y; Edan G
    N Engl J Med; 2016 Nov; 375(18):1717-1725. PubMed ID: 27806235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474.
    van Esbroeck ACM; Janssen APA; Cognetta AB; Ogasawara D; Shpak G; van der Kroeg M; Kantae V; Baggelaar MP; de Vrij FMS; Deng H; Allarà M; Fezza F; Lin Z; van der Wel T; Soethoudt M; Mock ED; den Dulk H; Baak IL; Florea BI; Hendriks G; De Petrocellis L; Overkleeft HS; Hankemeier T; De Zeeuw CI; Di Marzo V; Maccarrone M; Cravatt BF; Kushner SA; van der Stelt M
    Science; 2017 Jun; 356(6342):1084-1087. PubMed ID: 28596366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The long path (s) of placing medicines on the market].
    Duguet C
    Med Sci (Paris); 2019 Mar; 35 Hors série n° 1():13-17. PubMed ID: 30943154
    [No Abstract]   [Full Text] [Related]  

  • 13. [Not Available].
    Funck-Brentano C; Ménard J
    Presse Med; 2016 Sep; 45(9):719-22. PubMed ID: 27666586
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceutical drug development: high drug prices and the hidden role of public funding.
    Annett S
    Biol Futur; 2021 Jun; 72(2):129-138. PubMed ID: 34554467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Pain: The Need and Hope for Opioid Alternatives.
    EBioMedicine; 2016 Mar; 5():1. PubMed ID: 27077094
    [No Abstract]   [Full Text] [Related]  

  • 16. Open letter on access to the BIA 10-2474 clinical trial data.
    Brøsen K; Funck-Brentano C; Kroemer HK; Pirmohamed M; Schwab M
    Lancet; 2017 Jan; 389(10065):156. PubMed ID: 27955829
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fight against COVID-19: market overview and pipeline of ongoing trials].
    Pontremoli R; Richard G; Vuddamalay G; Groux N
    Med Sci (Paris); 2020 Dec; 36(12):1225-1232. PubMed ID: 33211647
    [No Abstract]   [Full Text] [Related]  

  • 18. Computational proteome-wide screening predicts neurotoxic drug-protein interactome for the investigational analgesic BIA 10-2474.
    Molinski SV; Shahani VM; MacKinnon SS; Morayniss LD; Laforet M; Woollard G; Kurji N; Sanchez CG; Wodak SJ; Windemuth A
    Biochem Biophys Res Commun; 2017 Jan; 483(1):502-508. PubMed ID: 28007597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Bial 10-2474 Phase 1 Study-A Drug Development Perspective and Recommendations for Future First-in-Human Trials.
    Chaikin P
    J Clin Pharmacol; 2017 Jun; 57(6):690-703. PubMed ID: 28387940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulating Drug Prices while Increasing Innovation.
    Conti RM; Frank RG; Gruber J
    N Engl J Med; 2021 Nov; 385(21):1921-1923. PubMed ID: 34767322
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.